相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RecombinantMycobacterium bovisBCG is a promising platform to develop vaccines againstTrypansoma cruziinfection
I Bontempi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus
Julio Alonso-Padilla et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
TLR4 agonist protects againstTrypanosoma cruziacute lethal infection by decreasing cardiac parasite burdens
Liliana E. Villanueva-Lizama et al.
PARASITE IMMUNOLOGY (2020)
Estimating the current burden of Chagas disease in Mexico: A systematic review and meta-analysis of epidemiological surveys from 2006 to 2017
Audrey Arnal et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection
Meagan A. Barry et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Myocardial fibrosis in chagas disease and molecules related to fibrosis
Ana T. Chaves et al.
PARASITE IMMUNOLOGY (2019)
Chagas Disease: From Discovery to a Worldwide Health Problem
Karita Claudia Freitas Lidani et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Congenital Transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: An Observational Prospective Study
Pierre Buekens et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease
Kathryn Jones et al.
INFECTION AND IMMUNITY (2018)
Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico
Liliana E. Villanueva-Lizama et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
The rise of neglected tropical diseases in the new Texas
Peter J. Hotez
PLOS NEGLECTED TROPICAL DISEASES (2018)
Upregulation of Cardiac IL-10 and Downregulation of IFN-gamma in Balb/c IL-4(-/-) in Acute Chagasic Myocarditis due to Colombi Strain of Trypanosoma cruzi
Marcos Vinicius da Silva et al.
MEDIATORS OF INFLAMMATION (2018)
IL-17RA-Signaling Modulates CD8+T Cell Survival and Exhaustion During Trypanosoma cruzi Infection
Jimena Tosello Boari et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease
Christopher A. Seid et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Transferring Luminex® cytokine assays to a wall-less plate technology: Validation and comparison study with plasma and cell culture supernatants
Leroy Versteeg et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
A multi-parametric analysis of Trypanosoma cruzi infection: common pathophysiologic patterns beyond extreme heterogeneity of host responses
Julien Santi-Rocca et al.
SCIENTIFIC REPORTS (2017)
Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi
Marina N. Matos et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy
Vanaja Konduri et al.
INFECTION AND IMMUNITY (2017)
Likely Autochthonous Transmission of Trypanosoma cruzi to Humans, South Central Texas, USA
Sarah M. Gunter et al.
EMERGING INFECTIOUS DISEASES (2017)
Cardiac Magnetic Resonance-Verified Myocardial Fibrosis in Chagas Disease: Clinical Correlates and Risk Stratification
Marly Uellendahl et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2016)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Theo Vos et al.
LANCET (2016)
A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease
Meagan A. Barry et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
The BENEFIT Trial: Where Do We Go from Here?
Bernard Pecoul et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi
Catherine W. Cai et al.
PLOS PATHOGENS (2016)
Toxic Profile of Benznidazole in Patients with Chronic Chagas Disease: Risk Factors and Comparison of the Product from Two Different Manufacturers
I. Molina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity
E. C. Sabino et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy
C. A. Morillo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice
Viridiana Martinez-Campos et al.
VACCINE (2015)
Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation
Ceri A. Fielding et al.
IMMUNITY (2014)
Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
Israel Molina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cytokine Profiling in Chagas Disease: Towards Understanding the Association with Infecting Trypanosoma cruzi Discrete Typing Units (A BENEFIT TRIAL Sub-Study)
Cristina Poveda et al.
PLOS ONE (2014)
High Interleukin 17 Expression Is Correlated With Better Cardiac Function in Human Chagas Disease
Luisa M. D. Magalhaes et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Global economic burden of Chagas disease: a computational simulation model
Bruce Y. Lee et al.
LANCET INFECTIOUS DISEASES (2013)
Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi
Israel A. Quijano-Hernandez et al.
VACCINE (2013)
Deficient Regulatory T Cell Activity and Low Frequency of IL-17-Producing T Cells Correlate with the Extent of Cardiomyopathy in Human Chagas' Disease
Paulo Marcos Matta Guedes et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
IL-17RA Signaling Reduces Inflammation and Mortality during Trypanosoma cruzi Infection by Recruiting Suppressive IL-10-Producing Neutrophils
Jimena Tosello Boari et al.
PLOS PATHOGENS (2012)
Update in treatment of Chagas disease
Guillaume Le Loup et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice Role of CD4+ and CD8+ T cells
Alberto Yairh Limon-Flores et al.
VACCINE (2010)
IL-17 Produced during Trypanosoma cruzi Infection Plays a Central Role in Regulating Parasite-Induced Myocarditis
Paulo Marcos da Matta Guedes et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
An Estimate of the Burden of Chagas Disease in the United States
Caryn Bern et al.
CLINICAL INFECTIOUS DISEASES (2009)
Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities
Rodolfo Viotti et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
IL-23 Is Required for Protection against Systemic Infection with Listeria monocytogenes
Karen D. Meeks et al.
JOURNAL OF IMMUNOLOGY (2009)
Perspectives on Trypanosoma cruzi-Induced Heart Disease (Chagas Disease)
Herbert B. Tanowitz et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2009)
Immunopathology of natural infection with Trypanosoma cruzi in dogs
Julio Vladimir Cruz-Chan et al.
VETERINARY PARASITOLOGY (2009)
Therapeutic DNA Vaccine against Trypanosoma cruzi Infection in Dogs A Pilot Clinical Trial
Israel Alejandro Quijano-Hernandez et al.
ANIMAL BIODIVERSITY AND EMERGING DISEASES: PREDICTION AND PREVENTION (2008)
IL-10: The master regulator of immunity to infection
Kevin N. Couper et al.
JOURNAL OF IMMUNOLOGY (2008)
Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease
Juan M. Bustamante et al.
NATURE MEDICINE (2008)
Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice
Gilma Sanchez-Burgos et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2007)
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
Shabaana A. Khader et al.
NATURE IMMUNOLOGY (2007)
Pathogenesis of chronic Chagas heart disease
Jose Antonio Marin-Neto et al.
CIRCULATION (2007)
Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease - A marker of disease severity
CE Rochitte et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection
MN Kelly et al.
INFECTION AND IMMUNITY (2005)
Frequency of interferon-γ-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease
SA Laucella et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice
E Dumonteil et al.
INFECTION AND IMMUNITY (2004)
Pathophysiology of the heart in Chagas' disease: current status and new developments
MD Higuchi et al.
CARDIOVASCULAR RESEARCH (2003)
Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice
S Kumar et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
